相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inflammatory signaling in human tuberculosis granulomas is spatially organized
Mohlopheni J. Marakalala et al.
NATURE MEDICINE (2016)
Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
Martin Gengenbacher et al.
MBIO (2016)
Evaluation of Moxifloxacin-Containing Regimens in Pathologically Distinct Murine Tuberculosis Models
Si-Yang Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing
Rienk A. Rienksma et al.
BMC GENOMICS (2015)
Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
Scott M. Irwin et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
Jean-Philippe Lanoix et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Anne Lenaerts et al.
IMMUNOLOGICAL REVIEWS (2015)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Limited Activity of Clofazimine as a Single Drug in a Mouse Model of Tuberculosis Exhibiting Caseous Necrotic Granulomas
Scott M. Irwin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Philana Ling Lin et al.
NATURE MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas
Maria A. Duque-Correa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis
Matthew W. Carroll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Reduced Drug Uptake in Phenotypically Resistant Nutrient-Starved Nonreplicating Mycobacterium tuberculosis
Jansy Sarathy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Microbial Persistence and the Road to Drug Resistance
Nadia R Cohen et al.
CELL HOST & MICROBE (2013)
Early immunomodulatory effects of linezolid in a human whole blood endotoxin model
C. Lambers et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients
Mohideen S. Jawahar et al.
PLOS ONE (2013)
Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
Maria C. Kjellsson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
Emily R. Driver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
Ian M. Rosenthal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
Jamie Harper et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
Susan E. Dorman et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Myungsun Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
Philana Ling Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mycobacterium tuberculosis: success through dormancy
Martin Gengenbacher et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Comparative Studies Evaluating Mouse Models Used for Efficacy Testing of Experimental Drugs against Mycobacterium tuberculosis
Mary A. De Groote et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Nitroimidazoles for the treatment of TB: past, present and future
Tathagata Mukherjee et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters
Iris Keren et al.
MBIO (2011)
Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice
Stephen T. Reece et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Effect of linezolid on cytokine production capacity and plasma endotoxin levels in response to lipopolysaccharide stimulation of whole blood
Gaku Takahashi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2010)
Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability
Martin Gengenbacher et al.
MICROBIOLOGY-SGM (2010)
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
Susan E. Dorman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Biomarkers for Prostate Cancer
Danil V. Makarov et al.
ANNUAL REVIEW OF MEDICINE (2009)
Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment
Stephanie L. Davis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug-Tolerant, Not Drug-Resistant, Mycobacterium tuberculosis in the Guinea Pig
Zahoor Ahmad et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Structure-Activity Relationships of Antitubercular Nitroimidazoles. 1. Structural Features Associated with Aerobic and Anaerobic Activities of 4-and 5-Nitroimidazoles
Pilho Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
Marcus B. Conde et al.
LANCET (2009)
Foamy macrophages and the progression of the human tuberculosis granuloma
David G. Russell et al.
NATURE IMMUNOLOGY (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?
Ian M. Rosenthal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates
Laura E. Via et al.
INFECTION AND IMMUNITY (2008)
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
Srinivasa P. S. Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M-tuberculosis Persistence
Pascale Peyron et al.
PLOS PATHOGENS (2008)
Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles
Hirofumi Sasaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
William J. Burman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
New insights into the function of granulomas in human tuberculosis
T Ulrichs et al.
JOURNAL OF PATHOLOGY (2006)
Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models
AJ Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Ipr1 gene mediates innate immunity to tuberculosis
H Pan et al.
NATURE (2005)
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
分享论文
